SIRT1 contributes to neuroendocrine differentiation of prostate cancer

被引:24
|
作者
Ruan, Lin [1 ,2 ]
Wang, Lei [3 ]
Wang, Xiaosong [1 ,4 ]
He, Ming [1 ,4 ]
Yao, Xiaoguang [1 ,4 ]
机构
[1] Hebei Univ Chinese Med, Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Nephrol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Dept Urol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Univ Chinese Med, Coll Integrat Med, Shijiazhuang, Hebei, Peoples R China
关键词
prostate cancer; SIRT1; neuroendocrine; N-Myc; Akt; OXIDATIVE STRESS; CELL-SURVIVAL; RESISTANT; EXPRESSION; P53; PROMOTES; MODULATION; APOPTOSIS; AUTOPHAGY; GENOMICS;
D O I
10.18632/oncotarget.23111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epigenetic factor SIRT1 can promote prostate cancer progression, but it is unclear whether SIRT1 contributes to neuroendocrine differentiation. In this study, we showed that androgen deprivation can induce reactive oxygen species production and that reactive oxygen species, in turn, activate SIRT1 expression. The increased SIRT1 expression induces neuroendocrine differentiation of prostate cancer cells by activating the Akt pathway. In addition, the interaction between Akt and SIRT1 is independent of N-Myc and can drive the development of neuroendocrine prostate cancer when N-Myc is blocked. Furthermore, SIRT1 facilitates tumor maintenance, and targeting SIRT1 may reduce the tumor burden during androgen deprivation. Our findings suggest that SIRT1 is a potential target for therapeutic intervention.
引用
下载
收藏
页码:2002 / 2016
页数:15
相关论文
共 50 条
  • [1] A forward genetic screen identifies SIRT1 as a driver of neuroendocrine prostate cancer
    de Almeida, Francisca Nunes
    Vasciaveo, Alessandro
    Zou, Min
    Di Bernardo, Matteo
    Califano, Andrea
    Abate-Shen, Cory
    CANCER RESEARCH, 2023, 83 (07)
  • [2] SIRT1 expression is elevated in human prostate cancer
    Zhang, Y. F.
    Zhou, Q.
    Jiang, Y. J.
    Dai, Y.
    Huang, Q.
    MODERN PATHOLOGY, 2008, 21 : 193A - 193A
  • [3] SIRT1 expression is elevated in human prostate cancer
    Zhang, Y. F.
    Zhou, Q.
    Jiang, Y. J.
    Dai, Y.
    Huang, Q.
    LABORATORY INVESTIGATION, 2008, 88 : 193A - 193A
  • [4] Neuroendocrine differentiation contributes to prostate cancer progression and the novel development of an in vivo neuroendocrine model
    Evans, CP
    Busby, JE
    Kung, HJ
    Yang, JC
    JOURNAL OF UROLOGY, 2003, 169 (04): : 89 - 90
  • [5] SIRT1 is significantly elevated in mouse and human prostate cancer
    Huffman, Derek M.
    Grizzle, William E.
    Bamman, Marcas M.
    Kim, Jeong-su
    Eltoum, Isam A.
    Elgavish, Ada
    Nagy, Tim R.
    CANCER RESEARCH, 2007, 67 (14) : 6612 - 6618
  • [6] SIRT1 protein levels in cancer Tuning SIRT1 to the needs of a cancer cell
    Deppert, Wolfgang
    CELL CYCLE, 2008, 7 (19) : 2947 - 2948
  • [7] AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells
    Natani, Sirisha
    Dhople, Vishnu M.
    Parveen, Asha
    Sruthi, K. K.
    Khilar, Priyanka
    Bhukya, Supriya
    Ummanni, Ramesh
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (10):
  • [8] Neuroendocrine differentiation in prostate cancer
    Jiaoti Huang Department of Pathology
    The Journal of Biomedical Research, 2008, (02) : 106 - 106
  • [9] Neuroendocrine differentiation in prostate cancer
    Sun, Yin
    Niu, Junyang
    Huang, Jiaoti
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 148 - 162
  • [10] Prostate cancer and neuroendocrine differentiation
    Tan M.Ö.
    Karaoǧlan Ü.
    Çelik B.
    Ataoǧlu Ö.
    Biri H.
    Bozkirli I.
    International Urology and Nephrology, 1999, 31 (1) : 75 - 82